NCT02750358 2025-06-22
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Universitaire Ziekenhuizen KU Leuven
Çankırı Karatekin University
Çankırı Karatekin University
Memorial Sloan Kettering Cancer Center
University Hospital, Toulouse
Centre Hospitalier Universitaire, Amiens
University Hospital, Toulouse
Washington University School of Medicine
Universidade Federal do Triangulo Mineiro